Lido Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,846
| Closed | -$339K | – | 923 |
|
|
2021
Q2 | $339K | Buy |
1,846
+70
| +4% | +$12.9K | ﹤0.01% | 577 |
|
|
2021
Q1 | $272K | Buy |
1,776
+137
| +8% | +$21K | ﹤0.01% | 610 |
|
|
2020
Q4 | $256K | Buy |
+1,639
| New | +$256K | 0.01% | 598 |
|
|
2020
Q1 | – | Sell |
-4,768
| Closed | -$516K | – | 635 |
|
|
2019
Q4 | $516K | Sell |
4,768
-43
| -0.9% | -$4.65K | 0.02% | 339 |
|
|
2019
Q3 | $471K | Buy |
4,811
+2,659
| +124% | +$260K | 0.02% | 303 |
|
|
2019
Q2 | $281K | Buy |
2,152
+22
| +1% | +$2.87K | 0.02% | 399 |
|
|
2019
Q1 | $287K | Buy |
+2,130
| New | +$287K | 0.02% | 370 |
|